Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwards JE, et al; Infectious Diseases Society of America.

Clin Infect Dis. 2009 Mar 1;48(5):503-35.

Department of Medicine, Division of Infectious Diseases, University of Alabama at
Birmingham, Birmingham, Alabama 35294-0006, USA. This email address is being protected from spambots. You need JavaScript enabled to view it.

Guidelines for the management of patients with invasive candidiasis and mucosal
candidiasis were prepared by an Expert Panel of the Infectious Diseases Society
of America. These updated guidelines replace the previous guidelines published in
the 15 January 2004 issue of Clinical Infectious Diseases and are intended for
use by health care providers who care for patients who either have or are at risk
of these infections. Since 2004, several new antifungal agents have become
available, and several new studies have been published relating to the treatment
of candidemia, other forms of invasive candidiasis, and mucosal disease,
including oropharyngeal and esophageal candidiasis. There are also recent
prospective data on the prevention of invasive candidiasis in high-risk neonates
and adults and on the empiric treatment of suspected invasive candidiasis in
adults. This new information is incorporated into this revised document.